CN105056057A - Pharmaceutical preparation for treating bronchial asthma - Google Patents

Pharmaceutical preparation for treating bronchial asthma Download PDF

Info

Publication number
CN105056057A
CN105056057A CN201510552777.3A CN201510552777A CN105056057A CN 105056057 A CN105056057 A CN 105056057A CN 201510552777 A CN201510552777 A CN 201510552777A CN 105056057 A CN105056057 A CN 105056057A
Authority
CN
China
Prior art keywords
parts
bronchial asthma
pharmaceutical preparation
treatment
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510552777.3A
Other languages
Chinese (zh)
Inventor
卞毓平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Zhengkuan Pharmaceutical Technology Co Ltd
Original Assignee
Nanjing Zhengkuan Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Zhengkuan Pharmaceutical Technology Co Ltd filed Critical Nanjing Zhengkuan Pharmaceutical Technology Co Ltd
Priority to CN201510552777.3A priority Critical patent/CN105056057A/en
Publication of CN105056057A publication Critical patent/CN105056057A/en
Pending legal-status Critical Current

Links

Abstract

The invention belongs to the field of traditional Chinese medicine preparations and particularly provides a pharmaceutical preparation for treating the bronchial asthma. The pharmaceutical preparation for treating the bronchial asthma is prepared by 25 parts of pachysandra, 28 parts of costus speciosus, 30 parts of moellendorf's spidemoss herb, 18 parts of phyllodium longipes, 25 parts of inula flower, 15 parts of snakegourd fruits, 20 parts of dark plum, 20 parts of blackberry lily, 25 parts of pinellia ternata, 25 parts of white atractylodes rhizome, 20 parts of cinnamon, 15 parts of almonds, 18 parts of white mulberry root barks, 15 parts of dayflower and 5 parts of licorice. The pharmaceutical preparation can treat the bronchial asthma.

Description

A kind of pharmaceutical preparation being used for the treatment of bronchial asthma
Technical field
The present invention relates to technical field of traditional Chinese medicine preparation, be specifically related to a kind of pharmaceutical preparation being used for the treatment of bronchial asthma and its preparation method and application.
Background technology
Bronchial asthma is the chronic airway inflammation disease participated in by various kinds of cell and cellular component, this chronic inflammatory disease is relevant to airway hyperreactivity, the reversible airflow limitation that usual appearance is extensive and changeable, cause the symptoms such as the panting of recurrent exerbation, tachypnea, uncomfortable in chest and (or) cough, how in night and (or) outbreak in early morning, aggravation, most of patients can spontaneous remission or alleviate through treatment.For this reason, be bursting to and develop the needs that more medicines for the treatment of bronchial asthma safely and effectively meet clinical treatment.
Summary of the invention
In order to solve the problem, the object of the present invention is to provide a kind of Chinese medicine preparation for the treatment of bronchial asthma disease.In order to reach this object, adopt following technical scheme:
Technical scheme: a kind of pharmaceutical preparation being used for the treatment of bronchial asthma, the active component contained by it by following raw materials in part by weight medicine extract be prepared from: careless 25 parts green for a long time, Costus speciosus 28 parts, Herba Selaginellae Moellendorfii 30 parts, row money set 18 parts, Flos Inulae 25 parts, Fructus Trichosanthis 15 parts, Fructus Mume 20 parts, Rhizoma Belamcandae 20 parts, the Rhizoma Pinelliae 25 parts, the Rhizoma Atractylodis Macrocephalae 25 parts, Cortex Cinnamomi 20 parts, 15 parts, Semen Armeniacae Amarum, Cortex Mori 18 parts, Herba Commelinae 15 parts, 5 parts, Radix Glycyrrhizae.
The described pharmaceutical preparation being used for the treatment of bronchial asthma, dosage form is pharmaceutically acceptable granule, tablet, capsule.
The described pharmaceutical preparation being used for the treatment of bronchial asthma, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
The described application of pharmaceutical preparation in preparation treatment bronchial asthma medicine being used for the treatment of bronchial asthma.
Grass green for a long time is Buxaceae powder stamen Buxus plant top stamen Herba Pachysandrae Stylosae PachysandraterminalisSieb.etZucc., with all herbal medicine.The whole year can adopt, and cleans cutting, dries.Dispelling wind stopping cough, relaxing muscles and tendons and activating QI and blood in the collateral, adjusting meridian and stopping leukorrhea.For chronic tracheitis, rheumatic arthritis, spasm of the calf, leucorrhea, amenorrhea, psychosis dysphoria.
Costus speciosus, Latin is called Costusspeciosus (Koen.) Smith, is Zingiberaceae Costus L herbaceos perennial, and like and grow under warm, moist environment, original producton location is Tropical Asia.Inducing diuresis to remove edema, detoxifying and relieving itching.For pertussis, oedema due to nephritis, urinary tract infection, cirrhotic ascites, dysuria; Urticaria is controlled in external, furuncle toxic swelling, otitis media.The present invention is with all herbal medicine.
Herba Selaginellae Moellendorfii is Selaginaceae Rock lily plant Herba Selaginellae Involventis SelaginellamoellendorfiiHieron., with all herbal medicine.The four seasons can adopt, and clean, dry.Clearing away heat-damp and promoting diuresis, hemostasis.For acute icterohepatitis, anasarca, hemoptysis of pulmonary tuberculosis, spits blood, bleeding hemorrhoids; Traumatic hemorrhage is controlled in external, burn and scald.
Row Qian Shuwei pulse family beggar-ticks rows of plants money tree Desmodiumpulchellum (L.) Benth., is used as medicine with root and leaf.Xia Qiu gathers, and summer shreds, and dries or using fresh herb.Clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving.For cold, fever, malaria, hepatitis, cirrhotic ascites, schistosomicide hepatosplenomegaly, rheumatalgia, traumatic injury.All the other Chinese medicines are pharmacopeia kind.
Beneficial effect: the traditional Chinese medical science thinks the lung being the dominator of QI, the kidney being the root of QI.When asthmatic attacks, lung road can not main gas, and suffering from a deficiency of the kidney can not improving inspiration by invigorating kidney-QI, then QI rising in reverse order is in upper, and sends out in dyspnea with rapid respiration.The spleen is the source of growth and development, spleen deficiency generating phlegm, stagnation of phlegm air flue, therefore see and breath with cough, and breathes hard.Therefore, asthma is the disease of kidney, lung, spleen, three void.The present invention's grass green for a long time, Costus speciosus, Herba Selaginellae Moellendorfii, row Qian Shu, Flos Inulae, Fructus Trichosanthis, Fructus Mume, Rhizoma Belamcandae, Rhizoma Pinelliae strengthening spleen, tonifying kidney, relieving cough and relieving asthma, regulate the flow of vital energy and eliminate the phlegm as monarch drug, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi, Semen Armeniacae Amarum, Cortex Mori, Herba Commelinae dispersing lung-QI and dissipating phlegm, antiasthmatic-antitussive are ministerial drug, Radix Glycyrrhizae is adjuvant, the mutual compatibility of full side, dispersing lung-QI and dissipating phlegm, antiasthmatic-antitussive, treatment bronchial asthma successful.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1, the preparation of granule embodiment: get careless 25g green for a long time, Costus speciosus 28g, Herba Selaginellae Moellendorfii 30g, row's money tree 18g, Flos Inulae 25g, Fructus Trichosanthis 15g, Fructus Mume 20g, Rhizoma Belamcandae 20g, Rhizoma Pinelliae 25g, Rhizoma Atractylodis Macrocephalae 25g, Cortex Cinnamomi 20g, Semen Armeniacae Amarum 15g, Cortex Mori 18g, Herba Commelinae 15g, Radix Glycyrrhizae 5g, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add starch 50g, granulate, make granule.
2, the preparation of Tablets Example: get careless 25g green for a long time, Costus speciosus 28g, Herba Selaginellae Moellendorfii 30g, row's money tree 18g, Flos Inulae 25g, Fructus Trichosanthis 15g, Fructus Mume 20g, Rhizoma Belamcandae 20g, Rhizoma Pinelliae 25g, Rhizoma Atractylodis Macrocephalae 25g, Cortex Cinnamomi 20g, Semen Armeniacae Amarum 15g, Cortex Mori 18g, Herba Commelinae 15g, Radix Glycyrrhizae 5g, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add dextrin 50g, granulate, tabletting, make tablet.
3, the preparation of capsule embodiment: get careless 25g green for a long time, Costus speciosus 28g, Herba Selaginellae Moellendorfii 30g, row's money tree 18g, Flos Inulae 25g, Fructus Trichosanthis 15g, Fructus Mume 20g, Rhizoma Belamcandae 20g, Rhizoma Pinelliae 25g, Rhizoma Atractylodis Macrocephalae 25g, Cortex Cinnamomi 20g, Semen Armeniacae Amarum 15g, Cortex Mori 18g, Herba Commelinae 15g, Radix Glycyrrhizae 5g, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add starch 50g, granulate, fill, make capsule.
4, pharmaceutical preparation treatment bronchial asthma of the present invention clinical research
4.1 general data: this pharmaceutical preparation is applied to clinical observation bronchial asthma case 60 example, wherein man 30 example, female 30 example, 17 ~ 56 years old age.The shortest person of the course of disease 4 months, most elder reaches 4 years.
4.2 diagnostic criterias: 1. recurrent exerbation pant, out of breath, uncomfortable in chest or cough, how with to contact allergen, cold air, physics, chemical irritation, viral upper respiratory tract infection, motion etc. relevant.2. during outbreak at two lung audible and be dispersed in or diffusivity, the wheezing sound based on expiratory phase, expiratory phase prolongation.3. above-mentioned symptom can be alleviated or spontaneous remission through treatment.4. panting except caused by other diseases, out of breath, uncomfortable in chest or cough.5. atypical symptoms person's (as without obviously panting or sign) should at least possess with the next item down test positive: (1) brinchial provocation test or the exercise test positive; (2) the Bronchodilation Test positive (FEV1 increases by more than 15%, and FEV1 absolute value increases >200ml); (3) in PEF day, aberration rate or day and night fluctuation rate >=20% meet above 1-4 bar or 4,5 persons, can be diagnosed as bronchial asthma.
4.3 test methods: prepare clinical sample by above-mentioned process for producing granula, specification is 10 grams every bag, within five days, is a course for the treatment of, one day three bags, take point early, middle and late three half an hour ante cibum.Period in a medicine is avoided eating anything raw or cold, pungent, stimulate and rotten thing.Blank group oral placebo granule five days is a course for the treatment of, one day three bags, point early, middle and late three half an hour ante cibum take.
4.4 criterions of therapeutical effect: recovery from illness: clinical symptoms all disappears, and test chamber inspection is normal.Take a turn for the better: clinical symptom relief, the state of an illness is controlled, lab testing improvement or normal.Invalid: clinical symptoms is without being clearly better or increasing the weight of.
4.5 therapeutic effect: in table 1.
Table 1 liang group comparitive study
Group n Recovery from illness Effectively Invalid Total effective rate (%)
Treatment group 30 8 19 3 90
Blank group 30 1 3 26 13.3
Visible, the medicine that the present invention obtains can safe and effective treatment bronchial asthma, and have no side effect.
4.6 Lee, female, 35 years old, suffers from bronchial asthma 2 years, show as recurrent exerbation pant, out of breath, uncomfortable in chest, lab testing confirmation is for bronchial asthma.Give the Chinese medicine that granule embodiment of the present invention provides, after 2 courses for the treatment of, clinical symptoms all disappears, and test chamber inspection is normal.

Claims (4)

1. one kind is used for the treatment of the pharmaceutical preparation of bronchial asthma, it is characterized in that, the active component contained by it by following raw materials in part by weight medicine extract be prepared from: careless 25 parts green for a long time, Costus speciosus 28 parts, Herba Selaginellae Moellendorfii 30 parts, row money set 18 parts, Flos Inulae 25 parts, Fructus Trichosanthis 15 parts, Fructus Mume 20 parts, Rhizoma Belamcandae 20 parts, the Rhizoma Pinelliae 25 parts, the Rhizoma Atractylodis Macrocephalae 25 parts, Cortex Cinnamomi 20 parts, 15 parts, Semen Armeniacae Amarum, Cortex Mori 18 parts, Herba Commelinae 15 parts, 5 parts, Radix Glycyrrhizae.
2. be used for the treatment of the pharmaceutical preparation of bronchial asthma as claimed in claim 1, it is characterized in that, dosage form is pharmaceutically acceptable granule, tablet, capsule.
3. be used for the treatment of the pharmaceutical preparation of bronchial asthma as claimed in claim 1, it is characterized in that, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
4. be used for the treatment of the application of pharmaceutical preparation in treatment bronchial asthma medicine of bronchial asthma according to claim 1.
CN201510552777.3A 2015-09-01 2015-09-01 Pharmaceutical preparation for treating bronchial asthma Pending CN105056057A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510552777.3A CN105056057A (en) 2015-09-01 2015-09-01 Pharmaceutical preparation for treating bronchial asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510552777.3A CN105056057A (en) 2015-09-01 2015-09-01 Pharmaceutical preparation for treating bronchial asthma

Publications (1)

Publication Number Publication Date
CN105056057A true CN105056057A (en) 2015-11-18

Family

ID=54485727

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510552777.3A Pending CN105056057A (en) 2015-09-01 2015-09-01 Pharmaceutical preparation for treating bronchial asthma

Country Status (1)

Country Link
CN (1) CN105056057A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111317787A (en) * 2020-03-25 2020-06-23 漳州片仔癀药业股份有限公司 Application of traditional Chinese medicine composition and preparation thereof in preparation of medicine for treating bronchial asthma

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094306A (en) * 1993-11-16 1994-11-02 张斌尚 The Chinese patent medicine of treatment bronchitis, bronchial asthma
CN1196953A (en) * 1998-05-05 1998-10-28 王立泉 Chinese patent drug for treating chronic bronchitis and asthma
CN101983675A (en) * 2010-11-08 2011-03-09 西安谦坤商务咨询管理有限公司 Traditional Chinese medicine composition for treating asthma and preparation method thereof
CN103211938A (en) * 2013-03-28 2013-07-24 宁波市镇海嘉慧知识产权服务有限公司 Traditional Chinese medicine composite for treating asthma

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094306A (en) * 1993-11-16 1994-11-02 张斌尚 The Chinese patent medicine of treatment bronchitis, bronchial asthma
CN1196953A (en) * 1998-05-05 1998-10-28 王立泉 Chinese patent drug for treating chronic bronchitis and asthma
CN101983675A (en) * 2010-11-08 2011-03-09 西安谦坤商务咨询管理有限公司 Traditional Chinese medicine composition for treating asthma and preparation method thereof
CN103211938A (en) * 2013-03-28 2013-07-24 宁波市镇海嘉慧知识产权服务有限公司 Traditional Chinese medicine composite for treating asthma

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111317787A (en) * 2020-03-25 2020-06-23 漳州片仔癀药业股份有限公司 Application of traditional Chinese medicine composition and preparation thereof in preparation of medicine for treating bronchial asthma

Similar Documents

Publication Publication Date Title
CN103191282B (en) Traditional Chinese medicinal composition for treating fever in children as well as preparation method and application thereof
CN104436150A (en) Traditional Chinese medicine composition used for treating rhinitis
CN105056057A (en) Pharmaceutical preparation for treating bronchial asthma
CN102552789B (en) Chinese medicine for treating damp-warm flu and preparation method and application thereof
CN105031497A (en) Medicinal preparation for treating chronic gastritis
CN110201059A (en) A kind of Chinese medicine composition and preparation method thereof for treating skin allergy and nettle rash
CN105106508A (en) Cocklebur fruit allergic rhinitis paste
CN104800464A (en) Traditional Chinese medicine for treating urticaria
CN103349726B (en) Traditional Chinese medicine for treating hiccup
CN103611006A (en) Traditional Chinese medicine for treating pityriasis rosea
CN104873879A (en) Medicinal preparation for treating insomnia
CN105434974A (en) Traditional Chinese medicine composition for treating mycoplasma pneumonia and preparation method
CN105983073A (en) Traditional Chinese medicine for treating allergic dermatitis
CN105106764A (en) Medicinal preparation for treating vomitus gravidarum
CN105412673A (en) Drug for treating Hashimoto disease and preparing method thereof
CN105106646A (en) Medicinal preparation for treating chronic pharyngitis
CN105288285A (en) Medicinal preparation for treating chronic bronchitis
CN104888080A (en) Traditional Chinese medicine composition for treating insomnia
CN105106684A (en) Pharmaceutical preparation for treating liver-yang hyperactivity type hypertension
CN104906439A (en) Medicine for treating chronic respiratory failure
CN104491019A (en) Traditional Chinese medicine for treating summer heat-dampness flu as well as preparation method and application of traditional Chinese medicine
CN104116029A (en) Health food for enhancing immunity and preparation method of health food
CN104000908A (en) Traditional Chinese medicine for treating pediatric pneumonia and preparation method thereof
CN103784633B (en) A kind of Chinese medicine composition treating infantile rhinitis and preparation method thereof
CN104758478A (en) Chinese medicine composite used for treating insomnia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151118